SCHEMBL20476397

SCHEMBL20476397

O=Cc1ccc2c(c1)CCN2C(=O)CCl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.51
CASP2 P42575 1/20 0.51
MAPT P10636 4/20 0.48
ALDH1A1 P00352 4/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
GAA P10253 1/20 0.48
HPGD P15428 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.46
NOTUM Q6P988 5/20 0.44
TSHR P16473 1/20 0.44
LMNA P02545 2/20 0.43
KDM4E B2RXH2 1/20 0.43
RAB9A P51151 1/20 0.43
CYP3A4 P08684 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
DRD2 P14416 1/20 0.41
DRD4 P21917 1/20 0.41
ALDH1A3 P47895 1/20 0.41
CYP11B1 P15538 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20476345 0.81 ALDH1A1 (0.53) MAPTALDH1A1MEN1KMT2AGAA
SCHEMBL7833255 0.81 NOTUM (0.65) MAPTALDH1A1MEN1KMT2AGAA
SCHEMBL18763042 0.79 SLC22A12 (0.58) CASP3CASP2MAPTALDH1A1MEN1
SCHEMBL28204772 0.78 ALDH1A1 (0.49) MAPTALDH1A1MEN1KMT2AGAA
SCHEMBL9181801 0.77 KDM4E (0.57) MAPTALDH1A1MEN1KMT2AGAA
SCHEMBL12194132 0.76 HPGD (0.64) ALDH1A1MEN1KMT2AGAAHPGD
SCHEMBL1928973 0.75 TSHR (0.75) CASP3MAPTALDH1A1MEN1KMT2A
SCHEMBL29770335 0.75 TSHR (0.75) CASP3MAPTALDH1A1MEN1KMT2A
SCHEMBL6646056 0.75 DRD4 (0.64) CASP3CASP2MAPTALDH1A1SMN1; SMN2
SCHEMBL14058976 0.75 CA1 (0.64) CASP3CASP2MAPTALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018150347-A1 COMPOUNDS WITH BETA-ADRENERGIC AGONIST AND ANTIMUSCARINIC ACTIVITY TORRENT PHARMACEUTICALS LIMITED (IN) 2018-08-23 WO disclosed